ULTRASENSITIVE PROSTATE-SPECIFIC ANTIGEN NADIR AND TIME TO NADIR AS INDEPENDENT PREDICTORS OF BIOCHEMICAL RECURRENCE IN PATIENTS AFTER RADICAL PROSTATECTOMY FOR LOCALIZED PROSTATE CANCER

被引：1
|
作者：
Vesely, S. [1 ,2 ]
Jarolim, L. [1 ,2 ]
Babjuk, M. [1 ,2 ]
Dusek, P. [1 ,2 ]
Kaliska, V. [1 ,2 ]
Schmidt, M. [1 ,2 ]
机构：
[1] Charles Univ Prague, Fac Med 2, Prague, Czech Republic
[2] Charles Univ Prague, Univ Hosp Motol, Dept Urol, Prague, Czech Republic
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2010年 / 9卷 / 02期
关键词：
D O I：
10.1016/S1569-9056(10)60848-2
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：274 / 274
页数：1
相关论文
共 50 条
  • [31] Ultrasensitive serum prostate specific antigen nadir accurately predicts the risk of early relapse after radical prostatectomy
    Shen, S
    Lepor, H
    Yaffee, R
    Taneja, SS
    JOURNAL OF UROLOGY, 2005, 173 (03): : 777 - 780
  • [32] Complexed prostate-specific antigen for the diagnosis of biochemical recurrence after radical prostatectomy
    Parsons, J. Kellogg
    Partin, Alan W.
    Trock, Bruce
    Bruzek, Debra J.
    Cheli, Carol
    Sokoll, Lori J.
    BJU INTERNATIONAL, 2007, 99 (04) : 758 - 761
  • [33] Race, biochemical disease recurrence, and prostate-specific antigen doubling time after radical prostatectomy
    Hamilton, Robert J.
    Aronson, William J.
    Presti, Joseph C., Jr.
    Terris, Martha K.
    Kane, Christopher J.
    Amling, Christopher L.
    Freedland, Stephen J.
    CANCER, 2007, 110 (10) : 2202 - 2209
  • [34] Nadir prostate-specific antigen best predicts the progression to androgen-independent prostate cancer
    Morote, J
    Trilla, E
    Esquena, S
    Abascal, JM
    Reventos, J
    INTERNATIONAL JOURNAL OF CANCER, 2004, 108 (06) : 877 - 881
  • [35] Erratum: Longitudinal modeling of ultrasensitive and traditional prostate-specific antigen and prediction of biochemical recurrence after radical prostatectomy
    Teemu D. Laajala
    Heikki Seikkula
    Fatemeh Seyednasrollah
    Tuomas Mirtti
    Peter J. Boström
    Laura L. Elo
    Scientific Reports, 7
  • [36] Inadequacy of prostate-specific antigen doubling time estimates calculated using an ultrasensitive assay of prostate-specific antigen for biochemical failure after radical prostatectomy
    Shimizu, Fumitaka
    Matsuyama, Yutaka
    Tominaga, Takashi
    Ohashi, Yasuo
    Fujime, Makoto
    UROLOGIA INTERNATIONALIS, 2007, 79 (04) : 356 - 360
  • [37] Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value (vol 16, e0249709, 2021)
    Chung, Jae Hoon
    Jeong, Jae Yong
    Lee, Ji Youl
    Song, Wan
    Kang, Minyong
    Sung, Hyun Hwan
    Jeon, Hwang Gyun
    Jeong, Byong Chang
    Seo, Seong I. L.
    Lee, Hyun Moo
    Jeon, Seong Soo
    PLOS ONE, 2022, 17 (06):
  • [38] Outcome of patients with hormone-refractory prostate cancer: Prognostic significance of prostate-specific antigen-doubling time and nadir prostate-specific antigen
    Tomioka, Susumu
    Shimbo, Masashi
    Amiya, Yoshiyasu
    Nakatsu, Hiroomi
    Murakami, Shino
    Shimazaki, Jun
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2008, 38 (01) : 36 - 42
  • [39] Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer
    Han, M
    Partin, AW
    Zahurak, M
    Piantadosi, S
    Epstein, JI
    Walsh, PC
    JOURNAL OF UROLOGY, 2003, 169 (02): : 517 - 523
  • [40] Usefulness of prostate-specific antigen nadir as predictor of androgen-independent progression of metastatic prostate cancer
    Morote, J
    Esquena, S
    Abascal, JM
    Trilla, E
    Cecchini, L
    Raventós, CX
    Orsola, A
    Planas, J
    Catalán, R
    Reventós, J
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2005, 20 (04): : 209 - 216
12345